Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentrations in a Hemodialysis Patient.

Suzuki S, Naito S, Numasawa Y, Asada M, Shoji N, Zeniya M, Takahashi D, Sato H, Iimori S, Nomura N, Sohara E, Okado T, Ishiwata Y, Nagata M, Rai T, Yokota T, Uchida S.

Intern Med. 2019 Jun 15;58(12):1775-1779. doi: 10.2169/internalmedicine.1785-18. Epub 2019 Feb 25.

2.

Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice.

Chen CY, Ueha S, Ishiwata Y, Yokochi S, Yang, Oppenheim JJ, Ogiwara H, Shichino S, Deshimaru S, Shand FHW, Shibayama S, Matsushima K.

J Immunother Cancer. 2019 Jan 29;7(1):21. doi: 10.1186/s40425-019-0503-6.

3.

Clozapine-Induced Acute Hyperglycemia Is Accompanied with Elevated Serum Concentrations of Adrenaline and Glucagon in Rats.

Nagata M, Kimura Y, Ishiwata Y, Takahashi H, Yasuhara M.

Biol Pharm Bull. 2018;41(8):1286-1290. doi: 10.1248/bpb.b18-00195.

4.

Population Pharmacokinetics of Intravenous Busulfan in Japanese Pediatric Patients With Primary Immunodeficiency Diseases.

Ishiwata Y, Nagata M, Tsuge K, Takahashi H, Suzuki S, Imai K, Takagi M, Kanegane H, Morio T, Yasuhara M.

J Clin Pharmacol. 2018 Mar;58(3):327-331. doi: 10.1002/jcph.1027. Epub 2017 Oct 27. No abstract available.

PMID:
29077206
5.

Combination of anti-CD4 antibody treatment and donor lymphocyte infusion ameliorates graft-versus-host disease while preserving graft-versus-tumor effects in murine allogeneic hematopoietic stem cell transplantation.

Ueha S, Yokochi S, Ishiwata Y, Kosugi-Kanaya M, Shono Y, Shibayama S, Ito S, Matsushima K.

Cancer Sci. 2017 Oct;108(10):1967-1973. doi: 10.1111/cas.13346. Epub 2017 Aug 29.

6.

Association of schizophrenia onset age and white matter integrity with treatment effect of D-cycloserine: a randomized placebo-controlled double-blind crossover study.

Takiguchi K, Uezato A, Itasaka M, Atsuta H, Narushima K, Yamamoto N, Kurumaji A, Tomita M, Oshima K, Shoda K, Tamaru M, Nakataki M, Okazaki M, Ishiwata S, Ishiwata Y, Yasuhara M, Arima K, Ohmori T, Nishikawa T.

BMC Psychiatry. 2017 Jul 12;17(1):249. doi: 10.1186/s12888-017-1410-3.

7.

Differences in sodium fluoride-18 uptake in the normal skeleton depending on the location and characteristics of the bone.

Nawata S, Kaneta T, Ogawa M, Ishiwata Y, Kobayashi N, Shishikura-Hino A, Yoshida K, Inaba Y, Saito T, Inoue T.

Nuklearmedizin. 2017 Jun 12;56(3):91-96. doi: 10.3413/Nukmed-0867-16-12. Epub 2017 May 10.

PMID:
28488727
8.

Quantification of temporal changes in calcium score in active atherosclerotic plaque in major vessels by 18F-sodium fluoride PET/CT.

Ishiwata Y, Kaneta T, Nawata S, Hino-Shishikura A, Yoshida K, Inoue T.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1529-1537. doi: 10.1007/s00259-017-3680-x. Epub 2017 Mar 27.

PMID:
28349280
9.

HLA haploidentical hematopoietic cell transplantation using clofarabine and busulfan for refractory pediatric hematological malignancy.

Takagi M, Ishiwata Y, Aoki Y, Miyamoto S, Hoshino A, Matsumoto K, Nishimura A, Tanaka M, Yanagimachi M, Mitsuiki N, Imai K, Kanegane H, Kajiwara M, Takikawa K, Mae T, Tomita O, Fujimura J, Yasuhara M, Tomizawa D, Mizutani S, Morio T.

Int J Hematol. 2017 May;105(5):686-691. doi: 10.1007/s12185-017-2187-3. Epub 2017 Feb 9.

PMID:
28185203
10.

Effects of Miconazole Oral Gel on Blood Concentrations of Tacrolimus and Cyclosporine: A Retrospective Observational Study.

Ishiwata Y, Nagata M, Arai T, Makiishi M, Yoshikawa M, Takahashi H, Kohsaka H, Yasuhara M.

Ther Drug Monit. 2016 Dec;38(6):717-721.

PMID:
27559841
11.

Mechanism Underlying Induction of Hyperglycemia in Rats by Single Administration of Olanzapine.

Nagata M, Nakajima M, Ishiwata Y, Takahashi Y, Takahashi H, Negishi K, Yasuhara M.

Biol Pharm Bull. 2016;39(5):754-61. doi: 10.1248/bpb.b15-00842.

12.

Haploidentical Bone Marrow Transplantation With Clofarabine and Busulfan Conditioning for a Child With Multiple Recurrent Acute Lymphoblastic Leukemia.

Aoki Y, Miyawaki R, Imai K, Takagi M, Kajiwara M, Ishiwata Y, Yasuhara M, Morio T, Mizutani S, Tomizawa D.

J Pediatr Hematol Oncol. 2016 Jan;38(1):e39-41. doi: 10.1097/MPH.0000000000000454.

PMID:
26523380
13.

Synthesis of Copper-Antimony-Sulfide Nanocrystals for Solution-Processed Solar Cells.

Suehiro S, Horita K, Yuasa M, Tanaka T, Fujita K, Ishiwata Y, Shimanoe K, Kida T.

Inorg Chem. 2015 Aug 17;54(16):7840-5. doi: 10.1021/acs.inorgchem.5b00858. Epub 2015 Aug 3.

PMID:
26237216
14.

Primary Palatoplasty for Unilateral Cleft Lip and Palate Using Mucosal Grafts and Flaps.

Torikai K, Kijima T, Hirakawa T, Naganishi H, Ishiwata Y, Fukawa T, Funaki J, Nagaoka R, Suzuki K, Sano T.

Cleft Palate Craniofac J. 2015 Sep;52(5):532-42. doi: 10.1597/13-323. Epub 2015 Apr 6.

PMID:
25844561
15.

Pharmacokinetic-pharmacodynamic analysis of sunitinib-induced thrombocytopenia in Japanese patients with renal cell carcinoma.

Nagata M, Ishiwata Y, Takahashi Y, Takahashi H, Saito K, Fujii Y, Kihara K, Yasuhara M.

Biol Pharm Bull. 2015;38(3):402-10. doi: 10.1248/bpb.b14-00636.

16.

Robust Antitumor Effects of Combined Anti-CD4-Depleting Antibody and Anti-PD-1/PD-L1 Immune Checkpoint Antibody Treatment in Mice.

Ueha S, Yokochi S, Ishiwata Y, Ogiwara H, Chand K, Nakajima T, Hachiga K, Shichino S, Terashima Y, Toda E, Shand FH, Kakimi K, Ito S, Matsushima K.

Cancer Immunol Res. 2015 Jun;3(6):631-40. doi: 10.1158/2326-6066.CIR-14-0190. Epub 2015 Feb 20.

17.

Effects of moxifloxacin on serum glucose concentrations in rats.

Ishiwata Y, Takahashi Y, Nagata M, Yasuhara M.

Biol Pharm Bull. 2013;36(4):686-90. Epub 2013 Jan 25.

18.

Characterization of acoustic cavitation in water and molten aluminum alloy.

Komarov S, Oda K, Ishiwata Y, Dezhkunov N.

Ultrason Sonochem. 2013 Mar;20(2):754-61. doi: 10.1016/j.ultsonch.2012.10.006. Epub 2012 Oct 23.

PMID:
23141190
19.

Effect of cimetidine on pentamidine induced hyperglycemia in rats.

Arino T, Karakawa S, Ishiwata Y, Nagata M, Yasuhara M.

Eur J Pharmacol. 2012 Oct 15;693(1-3):72-9. doi: 10.1016/j.ejphar.2012.07.043. Epub 2012 Aug 21.

PMID:
22968103
20.

Discovery, optimization, and pharmacological characterization of novel heteroaroylphenylureas antagonists of C-C chemokine ligand 2 function.

Laborde E, Macsata RW, Meng F, Peterson BT, Robinson L, Schow SR, Simon RJ, Xu H, Baba K, Inagaki H, Ishiwata Y, Jomori T, Matsumoto Y, Miyachi A, Nakamura T, Okamoto M, Handel TM, Bernard CC.

J Med Chem. 2011 Mar 24;54(6):1667-81. doi: 10.1021/jm1012903. Epub 2011 Feb 22.

21.

Pharmacodynamics of cibenzoline-induced hypoglycemia in rats.

Takahashi Y, Ishiwata Y, Kojima Y, Yasuhara M.

Drug Metab Pharmacokinet. 2011 Jun;26(3):242-7. doi: 10.2133/dmpk.DMPK-10-RG-127. Epub 2011 Jan 25.

22.

Gatifloxacin-induced histamine release and hyperglycemia in rats.

Ishiwata Y, Yasuhara M.

Eur J Pharmacol. 2010 Oct 25;645(1-3):192-7. doi: 10.1016/j.ejphar.2010.07.032. Epub 2010 Jul 30.

PMID:
20674567
23.

Concurrent administration of intravenous systemic and intravitreal methotrexate for intraocular lymphoma with central nervous system involvement.

Nakauchi Y, Takase H, Sugita S, Mochizuki M, Shibata S, Ishiwata Y, Shibuya Y, Yasuhara M, Miura O, Arai A.

Int J Hematol. 2010 Jul;92(1):179-85. doi: 10.1007/s12185-010-0589-6. Epub 2010 May 13.

PMID:
20464643
24.

Simultaneous determination of some phenothiazine derivatives in human blood by headspace solid-phase microextraction and gas chromatography with nitrogen-phosphorus detection.

Shinmen N, Lee XP, Kumazawa T, Hasegawa C, Ishiwata Y, Sato K, Seno H, Suzuki O.

J AOAC Int. 2008 Nov-Dec;91(6):1354-62.

PMID:
19202796
25.

Giant negative thermal expansion in magnetic nanocrystals.

Zheng XG, Kubozono H, Yamada H, Kato K, Ishiwata Y, Xu CN.

Nat Nanotechnol. 2008 Dec;3(12):724-6. doi: 10.1038/nnano.2008.309. Epub 2008 Oct 19.

PMID:
19057591
26.

Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by ECI301, an active variant of macrophage inflammatory protein-1alpha.

Shiraishi K, Ishiwata Y, Nakagawa K, Yokochi S, Taruki C, Akuta T, Ohtomo K, Matsushima K, Tamatani T, Kanegasaki S.

Clin Cancer Res. 2008 Feb 15;14(4):1159-66. doi: 10.1158/1078-0432.CCR-07-4485.

27.
28.

Effects of acute renal failure and ganciclovir on the pharmacodynamics of levofloxacin-induced seizures in rats.

Ishiwata Y, Son K, Itoga Y, Yasuhara M.

Biol Pharm Bull. 2007 Apr;30(4):745-50.

29.

Effect of levofloxacin on serum glucose concentration in rats.

Ishiwata Y, Itoga Y, Yasuhara M.

Eur J Pharmacol. 2006 Dec 3;551(1-3):168-74. Epub 2006 Sep 12.

PMID:
17026994
30.

Effects of gatifloxacin on serum glucose concentration in normal and diabetic rats.

Ishiwata Y, Sanada Y, Yasuhara M.

Biol Pharm Bull. 2006 Mar;29(3):527-31.

31.

Effect of isoniazid on the pharmacodynamics of cefazolin-induced seizures in rats.

Ishiwata Y, Nagata M, Yasuhara M.

Drug Metab Pharmacokinet. 2005 Apr;20(2):117-20.

32.

Seasonal changes of serum 25-hydroxyvitamin D and intact parathyroid hormone levels in a normal Japanese population.

Ono Y, Suzuki A, Kotake M, Zhang X, Nishiwaki-Yasuda K, Ishiwata Y, Imamura S, Nagata M, Takamoto S, Itoh M.

J Bone Miner Metab. 2005;23(2):147-51.

PMID:
15750693
33.

Modulation of masticatory muscle activity by tongue position.

Takahashi S, Kuribayashi G, Ono T, Ishiwata Y, Kuroda T.

Angle Orthod. 2005 Jan;75(1):35-9.

PMID:
15747813
34.

Control of bacteriophage T4 tail lysozyme activity during the infection process.

Kanamaru S, Ishiwata Y, Suzuki T, Rossmann MG, Arisaka F.

J Mol Biol. 2005 Mar 4;346(4):1013-20. Epub 2005 Jan 25.

PMID:
15701513
35.

Observation of fluorapatite formation under hydrolysis of tetracalcium phosphate in the presence of KF by means of soft X-ray emission and absorption spectroscopy.

Kurmaev EZ, Matsuya S, Shin S, Watanabe M, Eguchi R, Ishiwata Y, Takeuchi T, Iwami M.

J Mater Sci Mater Med. 2002 Jan;13(1):33-6.

PMID:
15348202
36.

Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist.

Kakizawa H, Itoh Y, Imamura S, Matsumoto T, Ishiwata Y, Ono Y, Yamamoto K, Kato T, Hayakawa N, Oda N, Goto Y, Goto Y, Nagasaka A, Senda T, Itoh M.

Horm Metab Res. 2004 Jul;36(7):458-64.

PMID:
15305228
37.

Blockade of CCR2 ameliorates progressive fibrosis in kidney.

Kitagawa K, Wada T, Furuichi K, Hashimoto H, Ishiwata Y, Asano M, Takeya M, Kuziel WA, Matsushima K, Mukaida N, Yokoyama H.

Am J Pathol. 2004 Jul;165(1):237-46.

38.

The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients.

Kakizawa H, Itoh M, Itoh Y, Imamura S, Ishiwata Y, Matsumoto T, Yamamoto K, Kato T, Ono Y, Nagata M, Hayakawa N, Suzuki A, Goto Y, Oda N.

Metabolism. 2004 May;53(5):550-5.

PMID:
15131756
39.

Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis.

Wada T, Furuichi K, Sakai N, Iwata Y, Kitagawa K, Ishida Y, Kondo T, Hashimoto H, Ishiwata Y, Mukaida N, Tomosugi N, Matsushima K, Egashira K, Yokoyama H.

J Am Soc Nephrol. 2004 Apr;15(4):940-8.

40.

Modulation of voluntary swallowing by visual inputs in humans.

Maeda K, Ono T, Otsuka R, Ishiwata Y, Kuroda T, Ohyama K.

Dysphagia. 2004 Winter;19(1):1-6.

PMID:
14745639
41.

CCR2 signaling contributes to ischemia-reperfusion injury in kidney.

Furuichi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, Hashimoto H, Ishiwata Y, Asano M, Wang H, Matsushima K, Takeya M, Kuziel WA, Mukaida N, Yokoyama H.

J Am Soc Nephrol. 2003 Oct;14(10):2503-15.

42.

Effects of experimental nasal obstruction on human masseter and suprahyoid muscle activities during sleep.

Hiyama S, Ono T, Ishiwata Y, Kuroda T, Ohyama K.

Angle Orthod. 2003 Apr;73(2):151-7.

PMID:
12725371
43.

Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury.

Furuichi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, Hashimoto H, Ishiwata Y, Tomosugi N, Mukaida N, Matsushima K, Egashira K, Yokoyama H.

J Am Soc Nephrol. 2003 Apr;14(4):1066-71.

44.

Hemispheric dominance of tongue control depends on the chewing-side preference.

Shinagawa H, Ono T, Ishiwata Y, Honda E, Sasaki T, Taira M, Iriki A, Kuroda T.

J Dent Res. 2003 Apr;82(4):278-83.

PMID:
12651931
45.

Non-steroidal anti-inflammatory drug, nabumetone, prevents indometacin-induced gastric damage via inhibition of neutrophil functions.

Ishiwata Y, Okamoto M, Yokochi S, Hashimoto H, Nakamura T, Miyachi A, Naito Y, Yoshikawa T.

J Pharm Pharmacol. 2003 Feb;55(2):229-37.

PMID:
12635655
46.

Long-term treatment with propagermanium suppresses atherosclerosis in WHHL rabbits.

Eto Y, Shimokawa H, Tanaka E, Morishige K, Fuchigami M, Ishiwata Y, Matsushima K, Takeshita A.

J Cardiovasc Pharmacol. 2003 Feb;41(2):171-7.

PMID:
12548076
47.

First night effect of an interocclusal appliance on nocturnal masticatory muscle activity.

Hiyama S, Ono T, Ishiwata Y, Kato Y, Kuroda T.

J Oral Rehabil. 2003 Feb;30(2):139-45.

PMID:
12535139
48.

Effects of mandibular position and body posture on nasal patency in normal awake subjects.

Hiyama S, Ono T, Ishiwata Y, Kuroda T.

Angle Orthod. 2002 Dec;72(6):547-53.

PMID:
12518946
49.

Breathing modes, body positions, and suprahyoid muscle activity.

Takahashi S, Ono T, Ishiwata Y, Kuroda T.

J Orthod. 2002 Dec;29(4):307-13; discussion 279.

PMID:
12444272
50.

Comparison of the sizes of adenoidal tissues and upper airways of subjects with and without cleft lip and palate.

Imamura N, Ono T, Hiyama S, Ishiwata Y, Kuroda T.

Am J Orthod Dentofacial Orthop. 2002 Aug;122(2):189-94; discussion 194-5.

PMID:
12165773

Supplemental Content

Loading ...
Support Center